LivaNova PLC (LSE:LIVN) - Overview

Stock Report

LivaNova PLC LIVN

Last Price
$45.22

Day Change
-0.10|-0.23%

As of 09/12/2016
16:45:12 GMT | USD
Minimum 15 Minutes Delay.

Last Close45.32
Day Range44.25 - 46.50
Mkt Cap2.19Bil
52-Wk Range41.21 - 69.17
Yield %0.00
ISINGB00BYMT0J19
Volume2,699
P/E-0.36
P/S0.02
P/CF-1.10

Share Price

Total Returns 09/12/2016

 Chg (%)  
More ...
LivaNova PLC5.83 
FTSE 100 TR GBP2.06
 
Financials
201320142015
More ...
Income Statement
Turnover--604.51
Operating Profit---34.48
Net Profit---42.34
Reported EPS---129.42
Balance Sheet
Current Assets--636.13
Non Current Assets--1,899.05
Total Assets--2,535.18
Current Liabilities--335.84
Total Liabilities--725.32
Total Equity--1,809.86
Cash Flow
Operating Cash Flow---13.51
Net Change in Cash---16.34
Broker Forecasts
Year EndingPre-taxEPSEPSgP/EPEGDPSYld %
More ...
'Broker Forecasts' provides consensus figures based on several brokers' views
--------
--------
Director Dealings
TradedActionNotifierPriceAmountValue
More ...
18/11/2016Transfer inMr. Andre-Michel Ballester0.009,4530.00
09/11/2016Transfer inMr. Hugh Morrison0.001,2150.00
24/05/2016SaleMr. Daniel Moore5,009.0070035,063.00
23/05/2016SaleMr. Daniel Moore5,007.3330015,022.00

Company Profile

LivaNova PLC is a medical technology company formed by the merger of Sorin S.p.A, engaged in the treatment of cardiovascular diseases, and Cyberonics Inc., a medical device company with core expertise in neuromodulation.
 

Sector

Medical Devices

Market Position

of Companies

Index

Outlook

(02/11/2016) "The company now expects revenue growth on a constant-currency basis to be in the 1.00% to 2.00% range, and is narrowing the projected range for adjusted diluted earnings per share (EPS) to $2.95 to $3.05"

Next Event 31/12/2016

Next year end (to be reported)
Ratios
CompSecMkt
More ...
PER (E)0.0017.1916.09
Div Yld (E)0.001.954.23
PEG (E)0.001.570.59
ROCE6.8133.8179.03
Op Mrgn10.26-23.40-13.33
EPS Grwth0.0016.3122.92
Dividends
PreviousLatest
More ...
Record Datet.b.c.t.b.c.
Ex-Divt.b.c.t.b.c.
Paidt.b.c.t.b.c.
Amnt0.000.00

Broker Sentiment

Strong Buy0
Buy0
Hold0
Sell0
Strong Sell0
  • Strong Sell
  • Strong Buy
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
More ...
Disclaimer
Directors
More ...
ChairmanMr. Daniel Moore
Chief Executive OfficerMr. Andre-Michel Ballester
AJ Bell includes AJ Bell Holdings Limited and its wholly owned subsidiaries. AJ Bell Management Limited and AJ Bell Securities Limited are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at Trafford House, Chester Road, Manchester M32 0RS. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.
© Copyright 2016 Morningstar. All rights reserved.